Pedro Eerdmans
Profile
Pedro Eerdmans is a professional who has worked as a Medical Director at Biosensors International USA, a Principal at Medtronic, Inc., and a Chief Medical Officer at Symetis SA. He holds a doctorate degree from Maastricht University and a graduate degree from Université Libre de Bruxelles.
Former positions of Pedro Eerdmans
| Companies | Position | End |
|---|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
| SYMETIS SA | Chief Tech/Sci/R&D Officer | - |
Biosensors International USA
 Biosensors International USA Electronic Equipment/InstrumentsElectronic Technology Biosensors International USA is a minority-owned business that provides medical devices. It develops, manufactures and commercializes innovative medical devices used in interventional cardiology. The company was founded in 1990 and is located in Newport Beach, CA | Chief Tech/Sci/R&D Officer | - |
Training of Pedro Eerdmans
| Maastricht University | Doctorate Degree |
| Université Libre de Bruxelles | Graduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
Biosensors International USA
Biosensors International USA Electronic Equipment/InstrumentsElectronic Technology Biosensors International USA is a minority-owned business that provides medical devices. It develops, manufactures and commercializes innovative medical devices used in interventional cardiology. The company was founded in 1990 and is located in Newport Beach, CA | Electronic Technology |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Symetis SA
 Symetis SA BiotechnologyHealth Technology Symetis SA develops minimally invasive heart valve replacement devices. Its products include ACURATE TA and ACURATE neo. The company was founded by Simon P. Hoerstrup and Gregor Zünd on September 5, 2001 and is headquartered in Ecublens, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Pedro Eerdmans
